Concepedia

Dong Xi

DX

Statistics

Publications

11

Citations

283

H-Index

10

Active since

2013

Affiliations

Novartis (Switzerland)(Current)

Tris Pharma (United States)

Northwestern University

Novartis (United States)

Medical University of Vienna

Dong Xi is an author at Novartis (Switzerland) specializing in biostatistics, public health, and experimental design.

Publications per year

2013–2025

11

Publications

11

A class of improved hybrid Hochberg-Hommel type step-up multiple test procedures

Jiangtao Gou, Ajit C. Tamhane, Dong Xi et al. · Biometrika · 2014 · 48 citations

Public Health, Biostatistics, Econometrics +8

Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials

Mouna Akacha, Janice Branson, Frank Bretz et al. · Statistics in Biopharmaceutical Research · 2020 · 45 citations · Full text

Health Professions, Health Policy, Clinical Data Management +16

Public face and private thrift in <scp>C</scp>hinese consumer behaviour

Lin Li, Dong Xi, Richard M. Lueptow · International Journal of Consumer Studies · 2013 · 31 citations

Business, Marketing, Marketing Management +9

On the Optimal Timing of Futility Interim Analyses

Dong Xi, Paul Gallo, David Ohlssen · Statistics in Biopharmaceutical Research · 2017 · 29 citations · Full text

Public Health, Biostatistics, Clinical Trial Regulation +12

Explaining relationships between chemical structure and tar-rich coal pyrolysis products yield based on Pearson correlation coefficient

Zhi Zhang, Anning Zhou, Zhiwei Shi et al. · Fuel · 2025 · 29 citations

Engineering, Chemical Engineering, Chemistry +10

1–5 of 11